CytoMed Therapeutics Has Obtained Board Approval To Launch, Pilot Program To Isolate And Cryo-Store Peripheral Blood Mononuclear Cells For And As A Reward To Loyal Shareholders Of CytoMed On Complimentary Basis, The Program Will Commence On June 1, 2024
CytoMed Therapeutics已獲得董事會批准啓動試點計劃,該計劃將於2024年6月1日啓動,該計劃將分離和冷凍儲存外周血單個核細胞,作爲對CytoMed忠實股東的免費獎勵